IntraLinks announced the results of the IntraLinks Global Investigator Site Survey. The survey looked at what methods are currently used for clinical trial document exchange, and the effectiveness of those methods. Eighty three percent of the respondents were clinical research coordinators, investigators and subinvestigators.
The survey findings show that the majority of investigator sites are using traditional methods–e-mail, courier, and fax–as a primary tool for clinical trial document exchange. A relatively small number of respondents are using web-based document exchange tools as their primary method:
· 73% of respondents use traditional methods – email (52%), courier (12%) and fax (nine percent)–as their primary tool for clinical trial document exchange
· 25% of respondents use web-based document exchange tools as their main way of exchanging clinical trial documents
The survey results indicate that investigator sites are experiencing significant inefficiencies and productivity challenges as a result of the ongoing use of email, courier and fax:
· 59% of respondents track due dates for information, current status or milestones manually
· 66% of respondents spend at least two hours, and in some cases more than nine hours, per week searching for documents
· 74% of respondents report resending documents to sponsors and Contract Research Organizations (CROs) at least once or twice, and in some cases more than five times, a week
The survey found that respondents recognize the benefits of web-based clinical document exchange tools:
· 68% of respondents cited being able to access updated information right away and reducing the amount of paper they use as advantages
· 62% of respondents cited being able to keep track of information easily as a benefit
· 47% of respondents cited not spending as much time searching for information as a benefit
The survey findings also showed that most respondents are conducting numerous studies and those that use online clinical tools such as electronic data capture and clinical portals have a significant number of passwords and logins:
· 87% of respondents have conducted three to 15+ studies over the last 12 months
· 57% of respondents are running four to 15+ concurrent studies
· 47% of respondents have at least three to ten passwords and logins, while another 20% have more than ten
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.